Indivior Pharmaceuticals (INDV) Current Leases (2021 - 2026)
Indivior Pharmaceuticals (INDV) posted quarterly Current Leases of $9.0 million for Q1 2026, down 18.18% year-over-year from $11.0 million in Q1 2025, and down 10.0% quarter-over-quarter from $10.0 million in Q4 2025.
Indivior Pharmaceuticals (INDV) Current Leases (2021 - 2026) Analysis & Trends
Indivior Pharmaceuticals' Current Leases history runs 6 years deep, the most recent figure standing at $9.0 million for Q1 2026.
- In Q1 2026, Current Leases fell 18.18% year-over-year to $9.0 million; the TTM figure through Mar 2026 stood at $9.0 million (down 18.18% YoY), while the FY2025 annual figure was $10.0 million, changed 0.0% from the prior year.
- Current Leases for Q1 2026 stood at $9.0 million, down from $10.0 million in the prior quarter.
- The five-year high for Current Leases was $11.0 million in Q1 2025, with the low at $8.0 million in Q4 2022.
- The 5-year median for Current Leases is $10.0 million (2024), against an average of $9.8 million.
- The sharpest annual moves came in 2023 and 2026: Current Leases gained 12.5% in 2023, then retreated 18.18% in 2026.
- Indivior Pharmaceuticals' Current Leases stood at $8.0 million in 2022, then increased by 12.5% to $9.0 million in 2023, then rose by 11.11% to $10.0 million in 2024, then changed by 0.0% to $10.0 million in 2025, then declined by 10.0% to $9.0 million in 2026.
- Business Quant data shows INDV's Current Leases at $9.0 million in Q1 2026, $10.0 million in Q4 2025, and $10.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Indivior Pharmaceuticals | 4.53 Bn | 4.31 Bn | 294.00 Mn | 9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.00 Mn |
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | 10.00 Mn |
| Sep 30, 2025 | 10.00 Mn |
| Jun 30, 2025 | 11.00 Mn |
| Mar 31, 2025 | 11.00 Mn |
| Dec 31, 2024 | 10.00 Mn |
| Dec 31, 2023 | 9.00 Mn |
| Dec 31, 2022 | 8.00 Mn |
| Dec 31, 2021 | 8.00 Mn |